NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+18.05%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.57B
AUM Growth
+$1.57B
Cap. Flow
-$106M
Cap. Flow %
-6.78%
Top 10 Hldgs %
82.2%
Holding
38
New
3
Increased
3
Reduced
1
Closed
4

Top Buys

1
SYBX icon
Synlogic
SYBX
$18.6M
2
SBBP
Strongbridge Biopharma plc.
SBBP
$16.3M
3
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.89M
4
AKTX
Akari Therapeutics
AKTX
$1.38M
5
AVTX icon
Avalo Therapeutics
AVTX
$1.2M

Top Sells

1
SUPN icon
Supernus Pharmaceuticals
SUPN
$107M
2
MM
MILLENNIAL MEDIA INC COM STK (DE)
MM
$14.4M
3
TRVN
Trevena, Inc.
TRVN
$10.5M
4
CVT
CVENT, INC.
CVT
$8.22M
5
ECOM
CHANNELADVISOR CORPORATION
ECOM
$5.53M

Sector Composition

1 Healthcare 72.28%
2 Communication Services 8.63%
3 Technology 7.87%
4 Consumer Discretionary 1.49%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARQL
26
DELISTED
Arqule Inc
ARQL
$5.47M 0.35% 2,520,316 – –
ZSAN
27
DELISTED
Zosano Pharma Corporation
ZSAN
$4.92M 0.31% 2,158,543 – –
DZSI
28
DELISTED
DZS Inc. Common Stock
DZSI
$4.78M 0.3% 4,781,290 – –
ROKA
29
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$3.96M 0.25% 3,220,433 – –
PRTK
30
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.37M 0.15% 125,004 – –
GYRE icon
31
Gyre Therapeutics
GYRE
$703M
$2.04M 0.13% 652,380 – –
AKTX
32
Akari Therapeutics
AKTX
$24.8M
$1.77M 0.11% 121,970 +95,076 +354% +$1.38M
AGRX
33
DELISTED
Agile Therapeutics, Inc
AGRX
$1.3M 0.08% 133,488 – –
AVTX icon
34
Avalo Therapeutics
AVTX
$122M
$1.2M 0.08% +595,435 New +$1.2M
SUPN icon
35
Supernus Pharmaceuticals
SUPN
$2.53B
– – -7,641,250 Closed -$107M
ECOM
36
DELISTED
CHANNELADVISOR CORPORATION
ECOM
– – -556,692 Closed -$5.53M
CVT
37
DELISTED
CVENT, INC.
CVT
– – -244,106 Closed -$8.22M
MM
38
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
– – -8,224,752 Closed -$14.4M
1
2